Post-traumatic stress disorder (PTSD) is a psychological condition that arises following exposure to a traumatic event, including but not limited to sexual assault, domestic violence, child abuse, military combat and related traumas, natural catastrophes, loss of a loved one, vehicular accidents, or other life-threatening or well-being-threatening incidents. Clinical manifestations can encompass intrusive thoughts, emotions, or nightmares associated with the traumatic experience, psychological or physiological distress triggered by trauma-related stimuli, deliberate efforts to evade such cues, cognitive and emotional dysregulation, and an exacerbated fight-or-flight reaction. These symptoms persist for over one month post-event and may involve specific triggers, such as misophonia. In young children, overt distress may be less apparent; instead, they might manifest their traumatic memories through repetitive play.
A majority of individuals exposed to traumatic events do not subsequently develop PTSD. Individuals subjected to interpersonal violence, including rape, other forms of sexual assault, abduction, stalking, intimate partner physical abuse, and childhood abuse, exhibit a higher propensity for developing PTSD compared to those who experience non-assaultive traumas like accidents and natural disasters. Annually, approximately 3.5% of adults in the United States are diagnosed with PTSD, with a lifetime prevalence rate reaching 9%. Globally, annual prevalence rates typically range from 0.5% to 1% in most other regions. Elevated prevalence rates are frequently observed in areas affected by armed conflict. The disorder demonstrates a higher incidence among women compared to men.
A recent systematic review and meta-analysis indicated that the combined prevalence rates for ICD-11 PTSD and complex PTSD were 2% and 4%, respectively, among adults residing in economically developed countries or regions not exposed to war. These rates escalated to 6% and 15%, respectively, in war-affected or less economically developed countries or regions.
Preventive interventions may prove effective when psychotherapy is specifically directed towards individuals exhibiting early symptoms, but they are not efficacious when universally applied to all trauma-exposed individuals irrespective of symptom presentation. The primary therapeutic approaches for individuals with PTSD involve psychotherapy and pharmacotherapy. Most combined therapeutic regimens, integrating psychotherapy and pharmacotherapy, do not appear to surpass the efficacy of psychotherapy alone, with the notable exception of MDMA-assisted psychotherapy. The therapeutic advantages derived from medication are generally less pronounced than those achieved through psychotherapy. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are the initial pharmacological treatments for PTSD, offering moderate benefits to approximately 50% of patients. Insufficient evidence supports the use of medications other than certain SSRIs or SNRIs, and benzodiazepines, in particular, may exacerbate clinical outcomes.
Manifestations of trauma-related psychological disorders have been recorded since antiquity, dating back to the era of the ancient Greeks. Historical accounts suggest the presence of post-traumatic illness during the seventeenth and eighteenth centuries, exemplified by Samuel Pepys' diary, which detailed intrusive and distressing symptoms subsequent to the 1666 Great Fire of London. Throughout the World Wars, this condition was identified by various appellations, such as "shell shock," "war nerves," neurasthenia, and "combat neurosis." The nomenclature "post-traumatic stress disorder" emerged in the 1970s, largely influenced by diagnoses among U.S. military veterans of the Vietnam War. Official recognition was granted by the American Psychiatric Association in 1980, with its inclusion in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III).
Clinical Presentation and Symptomatology
The onset of PTSD symptoms typically occurs within three months following the precipitating traumatic event, although manifestation can be delayed for several years. Characteristically, individuals with PTSD exhibit persistent avoidance of trauma-related thoughts, emotions, or discussions concerning the event, potentially experiencing dissociative amnesia regarding the trauma. Nevertheless, the traumatic experience is frequently re-experienced through intrusive, recurrent recollections, dissociative episodes such as "flashbacks," and nightmares, affecting 50% to 70% of individuals. Although post-traumatic symptoms are common, a diagnosis of PTSD requires their persistence for over one month post-trauma, reaching a severity that causes significant life dysfunction or clinical distress. Symptoms of clinically significant dysfunction or distress lasting less than one month post-trauma may indicate acute stress disorder. Conversely, some individuals may experience post-traumatic growth subsequent to a traumatic event. Social interactions experienced by trauma survivors can modulate PTSD symptomatology, exemplified by critical remarks from partners that induce feelings of guilt in the affected individual.
Comorbid Medical Conditions
Individuals who have experienced trauma frequently develop depression, anxiety disorders, and mood disorders, alongside PTSD. Over 50% of individuals diagnosed with PTSD present with comorbid anxiety, mood, or substance use disorders.
Substance use disorders, including alcohol use disorder, frequently co-occur with PTSD. The presence of comorbid substance use disorders can impede recovery from PTSD or other anxiety disorders, potentially exacerbating these conditions. Addressing these co-occurring issues can lead to significant improvements in an individual's mental health status and a reduction in anxiety levels.
A robust association exists between PTSD and tinnitus, with speculation suggesting that PTSD may contribute to the etiology of some tinnitus cases observed in conjunction with the disorder.
Furthermore, PTSD is linked to various physical health comorbidities characterized by inflammatory processes and immune system dysregulation.
Among children and adolescents, a significant correlation exists between difficulties in emotional regulation (e.g., mood swings, anger outbursts, temper tantrums) and post-traumatic stress symptoms, irrespective of age, gender, or the specific type of trauma experienced.
Moral injury, defined as moral distress encompassing shame or guilt subsequent to a perceived moral transgression, is associated with PTSD yet represents a distinct construct. Specifically, moral injury is characterized by associations with shame and guilt, whereas PTSD is primarily linked to anxiety and fear.
Risk Factors
Individuals identified as being at elevated risk for developing PTSD include combat military personnel, survivors of natural disasters, concentration camp survivors, and victims of violent crime. Furthermore, those employed in professions involving exposure to violence (e.g., soldiers) or disasters (e.g., emergency service workers) face increased vulnerability. Additional high-risk occupations encompass police officers, firefighters, first responders, ambulance personnel, healthcare professionals, train drivers, divers, journalists, sailors, and individuals working in banking, postal services, or retail. The severity of the traumatic event also correlates with a subsequent risk of PTSD development; experiences such as witnessed death, or witnessed or experienced torture, injury, bodily disfigurement, and traumatic brain injury are strongly linked to PTSD onset. Analogously, traumatic events that are unexpected or from which the victim cannot escape are likewise associated with a heightened risk of PTSD development.
Traumatic Events
PTSD is associated with exposure to a diverse array of traumatic events. The probability of developing PTSD post-trauma varies significantly by the type of traumatic exposure, with the highest risks observed following torture (40%) and sexual violence (11.4%), particularly rape (19.0%). While men exhibit a higher likelihood of experiencing any type of traumatic event, women are more prone to encountering high-impact traumatic events, such as interpersonal violence and sexual assault, which are strongly implicated in PTSD development.
Individuals who survive motor vehicle collisions, encompassing both children and adults, exhibit an elevated risk of developing PTSD. Globally, approximately 2.6% of adults receive a PTSD diagnosis after non-life-threatening traffic incidents, with a comparable prevalence observed in children. This risk nearly doubles to 4.6% following life-threatening vehicular accidents. Females demonstrate a higher propensity for PTSD diagnosis subsequent to road traffic accidents, irrespective of whether the incident occurred during childhood or adulthood.
Research has extensively investigated post-traumatic stress reactions in pediatric and adolescent populations. While the prevalence of PTSD may be lower in children compared to adults, symptoms can persist for decades without therapeutic intervention. One estimation indicates that in developed, non-conflict-affected nations, the proportion of children and adolescents experiencing PTSD is approximately 1%, contrasting with 1.5% to 3% among adults. On average, 16% of children exposed to a traumatic event develop PTSD, with incidence rates fluctuating based on exposure type and gender. Consistent with adult populations, pediatric risk factors for PTSD encompass female gender, disaster exposure, maladaptive coping mechanisms, and inadequate social support structures.
Predictive models consistently identify childhood trauma, chronic adversity, neurobiological variations, and familial stressors as factors associated with an elevated risk of PTSD following a traumatic event in adulthood. While consistently predictive event-specific aspects remain elusive, peritraumatic dissociation has emerged as a relatively consistent prognostic indicator for PTSD development. The proximity, duration, and severity of the traumatic experience significantly influence outcomes. Speculation suggests that interpersonal traumas may engender more severe psychological sequelae than impersonal ones, although this hypothesis remains contentious. Individuals subjected to physical abuse, physical assault, or kidnapping exhibit an augmented risk of developing PTSD. Furthermore, women who endure physical violence are more prone to developing PTSD compared to men.
Intimate Partner and Sexual Violence
Individuals exposed to domestic violence are predisposed to developing PTSD. A robust association exists between PTSD development in mothers who experience domestic violence during the perinatal period of their pregnancy.
Survivors of sexual assault or rape may develop symptoms of post-traumatic stress disorder. The probability of persistent PTSD symptoms increases if the assailant confined or restrained the victim, if the victim perceived a lethal threat, if the victim was exceptionally young or elderly, or if the assailant was known to the victim. Furthermore, the likelihood of sustained severe symptoms is exacerbated when the survivor's social environment ignores, is unaware of, or blames the victim for the assault.
War-Related Trauma and Refugee Populations
Military personnel are routinely exposed to traumatic events during wartime. Following deployment to combat zones, exposure to life-threatening situations is prevalent. Additional common exposures include experiencing injury or death, involvement in serious accidents, or handling human remains.
Combat-related military service constitutes a significant risk factor for PTSD development. Approximately 22% of individuals exposed to combat develop PTSD; notably, in about 25% of affected military personnel, the onset of PTSD symptoms is delayed.
Refugee populations also face an elevated risk of PTSD, attributable to their exposure to warfare, severe hardships, and traumatic events. Prevalence rates for PTSD among refugees vary widely, ranging from 4% to 86%. Although the psychological stresses of war impact all involved, displaced persons are disproportionately affected.
The challenges concerning the overall psychosocial well-being of refugees are inherently complex and individually nuanced. Refugees frequently exhibit diminished levels of well-being and a high incidence of mental distress, stemming from both past and ongoing traumatic experiences. Particularly vulnerable groups, whose needs often remain unaddressed, include women, older adults, and unaccompanied minors. Furthermore, the presence of post-traumatic stress and depression within refugee populations often negatively impacts their educational attainment.
Unexpected Death of a Loved One
Cross-national studies consistently identify the sudden, unexpected death of a loved one as the most frequently reported traumatic event. Nevertheless, most individuals experiencing such an event do not develop Post-Traumatic Stress Disorder (PTSD). A comprehensive analysis from the WHO World Mental Health Surveys indicated a 5.2% risk of PTSD development following the unexpected death of a loved one. Given the widespread occurrence of this traumatic event, the unexpected death of a loved one contributes to approximately 20% of global PTSD cases.
Life-Threatening or Severe Illness
Several medical conditions, including cancer, myocardial infarction (heart attack), and stroke, are linked to an elevated risk of PTSD. Specifically, 22% of cancer survivors exhibit lifelong symptoms resembling PTSD. Hospitalization in an intensive care unit (ICU) also constitutes a risk factor for PTSD. Furthermore, some women develop PTSD stemming from experiences associated with breast cancer and mastectomy. Family members of individuals facing life-threatening illnesses, such as parents of children with chronic conditions, are also susceptible to developing PTSD.
Psychosis Spectrum Conditions
Evidence indicates that individuals who have experienced psychotic episodes, characteristic of conditions like schizophrenia, schizoaffective disorder, and bipolar I disorder, face an elevated risk of developing PTSD. This heightened vulnerability often arises from traumatic experiences encountered during and after a psychotic episode. These traumatic events encompass, but are not restricted to, psychiatric hospitalizations, interactions with law enforcement, social stigmatization, embarrassment resulting from psychotic behavior, suicidal ideation and attempts, distressing delusions and hallucinations, and the apprehension or actual experience of losing control. The reported incidence of PTSD among psychosis survivors varies significantly, ranging from 11% to 67%.
Cancer
Estimates for the prevalence of cancer-related PTSD typically fall between 7% and 14%. Furthermore, an additional 10% to 20% of patients experience subsyndromal post-traumatic stress symptoms (PTSS). Both PTSD and PTSS are linked to heightened psychological distress and a diminished quality of life, affecting both recently diagnosed patients and long-term survivors.
The PTSD Field Trials conducted for the Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) indicated that 22% of cancer survivors exhibit lifetime cancer-related PTSD (CR-PTSD), identifying cancer diagnosis and its subsequent treatment as significant traumatic stressors.
Consequently, with the rising incidence of cancer diagnoses and advancements in cancer survivorship, cancer-related PTSD is emerging as a more critical concern. This underscores the growing importance of addressing both the physical and psychological needs of cancer patients.
Pregnancy-Related Trauma
Women who experience miscarriage are susceptible to developing PTSD. The risk of PTSD is further elevated in individuals who experience recurrent miscarriages compared to those with a single occurrence. Post-traumatic stress disorder can also manifest after childbirth, with the risk increasing if the woman has a history of trauma prior to pregnancy. The estimated prevalence of PTSD following uncomplicated childbirth (excluding stillbirth or significant complications) ranges from 2.8% to 5.6% at six weeks postpartum, decreasing to 1.5% by six months postpartum. While full PTSD is less common, post-traumatic stress symptoms are frequently observed after childbirth, with a prevalence of 24–30.1% at six weeks, declining to 13.6% at six months. Additionally, emergency childbirth is linked to an increased risk of PTSD.
Natural Disasters
Individuals exposed to natural disasters, including floods, earthquakes, tsunamis, hurricanes, and fires, are susceptible to developing post-traumatic stress disorder (PTSD). A comprehensive literature review conducted between 1980 and 2007 revealed that the incidence of PTSD following natural disasters was comparatively lower than that observed after human-made catastrophes. This review reported prevalence rates ranging from 3.7% to 60%. Specifically, studies indicate that approximately one-quarter of earthquake survivors (23.66%) experience PTSD. Key risk factors for PTSD development post-disaster encompass the severity of physical injury, perceived threat to life, and the number of fatalities witnessed. Furthermore, geographical proximity to the epicenter of a natural disaster has been identified as a contributing factor to PTSD onset. Such events frequently lead to family displacement and undermine individuals' perceptions of control and security. Effective mental health recovery strategies for individuals, communities, and nations following emergencies, including natural disasters, are crucial for both social stability and economic resilience. Consequently, robust mental health emergency preparedness and response mechanisms are essential in the aftermath of natural disasters.
Genetics
Evidence suggests a hereditary component to PTSD susceptibility. Genetic factors alone account for approximately 30% of the variance observed in PTSD. Studies involving twin pairs exposed to combat in Vietnam demonstrated that monozygotic (identical) twins of individuals with PTSD exhibited a heightened risk of developing the disorder compared to dizygotic (non-identical) twins. Preliminary findings also indicate that women with a smaller hippocampal volume may possess an increased predisposition to PTSD following traumatic experiences. Furthermore, research reveals significant shared genetic influences between PTSD and other psychiatric conditions. Specifically, panic disorder, generalized anxiety disorder, and PTSD share 60% of their genetic variance. Similarly, alcohol, nicotine, and drug dependence exhibit over 40% genetic commonalities. Neuroscientist Dr. Rachel Yehuda's research has explored the intergenerational transmission of psychological trauma, particularly focusing on Holocaust survivors and their descendants. Her team investigated the FKBP5 stress gene, which is associated with PTSD. The study's findings highlighted the genetic underpinnings of PTSD by demonstrating an effect on FKBP5 gene methylation in both the parents who endured trauma in concentration camps and their offspring.
Evolutionary Perspectives
From the viewpoints of Evolutionary Psychiatry and Evolutionary Psychology, PTSD symptoms are conceptualized as extreme or dysregulated manifestations of defensive mechanisms that conferred survival advantages in ancestral environments. Manifestations such as hypervigilance, intrusive recollections, and exaggerated startle responses could signify an overactivation of adaptive mechanisms originally intended to enhance post-traumatic survival. Although these evolutionary frameworks offer valuable context for understanding symptom clusters, scholarly reviews underscore their theoretical nature and the necessity for their integration with neurobiological and psychosocial research.
Pathophysiology
Neuroendocrinology
The symptomatology of PTSD may arise from a traumatic event inducing an exaggerated adrenaline response, thereby establishing profound neurological patterns within the brain. These persistent patterns can endure significantly beyond the initial fear-inducing event, rendering individuals hyper-responsive to subsequent threatening scenarios. Elevated levels of stress hormones secreted during traumatic experiences are known to suppress hypothalamic activity, potentially representing a critical factor in PTSD pathogenesis.
PTSD induces distinct biochemical alterations in the brain and body, differentiating it from other psychiatric conditions like major depressive disorder. Patients diagnosed with PTSD exhibit a more pronounced response to the dexamethasone suppression test compared to those with clinical depression.
A majority of individuals with PTSD demonstrate reduced cortisol secretion and elevated urinary catecholamine levels, resulting in a norepinephrine/cortisol ratio that is notably higher than in non-diagnosed counterparts. This physiological profile contrasts with the typical fight-or-flight response, where exposure to a stressor generally leads to increased levels of both catecholamines and cortisol.
Elevated brain catecholamine levels and increased corticotropin-releasing factor (CRF) concentrations are observed. Collectively, these observations indicate a dysregulation within the hypothalamic-pituitary-adrenal (HPA) axis.
The sustained experience of fear involves the hypothalamic-pituitary-adrenal (HPA) axis, the locus coeruleus-noradrenergic systems, and the neural pathways connecting the limbic system with the frontal cortex. The HPA axis, which orchestrates the hormonal response to stress and subsequently activates the locus coeruleus-noradrenergic system, is implicated in the excessive consolidation of memories following traumatic events. This heightened memory consolidation is associated with an increased propensity for developing Post-Traumatic Stress Disorder (PTSD). Furthermore, the amygdala plays a critical role in threat detection and the generation of both conditioned and unconditioned fear responses in reaction to perceived dangers.
The HPA axis is primarily responsible for regulating the body's hormonal response to stress. In individuals with PTSD, significant cortisol suppression in response to dexamethasone suggests that HPA axis dysregulation likely stems from a robust negative feedback inhibition of cortisol, which is attributed to an elevated sensitivity of glucocorticoid receptors.
PTSD is theorized to represent a maladaptive learning pathway for fear responses, mediated by a hypersensitive, hyperreactive, and hyperresponsive HPA axis.
Reduced cortisol levels may confer a predisposition to PTSD. For instance, a study of Swedish soldiers deployed to Bosnia and Herzegovina revealed that those with lower pre-service salivary cortisol levels exhibited a greater susceptibility to developing PTSD symptoms after experiencing war trauma, compared to soldiers with normal pre-service cortisol concentrations. Given cortisol's crucial role in re-establishing physiological homeostasis post-stress, it is hypothesized that trauma survivors with diminished cortisol experience a prolonged and more distressing stress response, thereby increasing their vulnerability to PTSD.
The locus coeruleus-noradrenergic system is believed to mediate the excessive consolidation of fear memories. Elevated cortisol concentrations typically attenuate noradrenergic activity; however, individuals with PTSD often exhibit reduced cortisol levels. This observation has led to the hypothesis that those with PTSD may be unable to modulate the heightened noradrenergic response to traumatic stress. Intrusive memories and conditioned fear responses are considered manifestations of reactions to associated triggers. Neuropeptide Y (NPY) has been documented to decrease norepinephrine release and has exhibited anxiolytic effects in animal models. Research indicates that individuals with PTSD present with diminished NPY levels, potentially signifying elevated anxiety.
Further research suggests that individuals with PTSD often exhibit chronically low serotonin levels, which contributes to frequently observed behavioral symptoms including anxiety, rumination, irritability, aggression, suicidality, and impulsivity. Serotonin also plays a role in stabilizing glucocorticoid production.
Dopamine concentrations in individuals with PTSD can influence symptom presentation: diminished levels may contribute to anhedonia, apathy, attentional deficits, and motor impairments, whereas elevated levels can be associated with psychosis, agitation, and restlessness.
Investigations have also identified elevated concentrations of the thyroid hormone triiodothyronine in individuals with PTSD. This particular form of type 2 allostatic adaptation might contribute to an augmented sensitivity to catecholamines and other stress-related mediators.
Sustained exposure to high stress can also induce hyperresponsiveness within the norepinephrine system. The overactivation of norepinephrine receptors in the prefrontal cortex may be linked to the recurrent flashbacks and nightmares characteristic of PTSD. Furthermore, a reduction in other norepinephrine-mediated functions, such as awareness of the immediate environment, can impede the brain's memory mechanisms from adequately processing traumatic experiences, leading to a dissociation between the emotions felt during a flashback and the actual current surroundings.
Significant debate persists within the medical community concerning the precise neurobiology of PTSD. A comprehensive review published in 2012, for instance, found no definitive correlation between cortisol levels and PTSD. Nevertheless, most studies report that individuals with PTSD exhibit elevated corticotropin-releasing hormone levels, reduced basal cortisol concentrations, and an augmented negative feedback suppression of the HPA axis by dexamethasone.
Neuroimmunology
Research on the peripheral immune system in individuals with PTSD indicates dysfunction, characterized by elevated cytokine levels and an increased susceptibility to immune-related chronic conditions. Furthermore, neuroimmune dysfunction in PTSD suggests a potentially suppressed central immune response, possibly due to diminished microglial activity in the brain during immune challenges. Compared to control groups, individuals with PTSD exhibit a reduced increase in the 18-kDa translocator protein, a marker of microglial activation, after lipopolysaccharide administration. This neuroimmune suppression correlates with more severe anhedonic symptoms. Consequently, researchers propose that therapeutic interventions targeting the restoration of neuroimmune function may effectively mitigate PTSD symptoms.
Neuroanatomy
A meta-analysis of structural magnetic resonance imaging (MRI) investigations revealed associations between PTSD and reduced total brain volume, intracranial volume, and the volumes of the hippocampus, insula cortex, and anterior cingulate. A significant portion of this research originated from studies on individuals who developed PTSD following exposure to the Vietnam War.
Individuals diagnosed with PTSD exhibit diminished brain activity within the dorsal and rostral anterior cingulate cortices, as well as the ventromedial prefrontal cortex, regions critically involved in emotional experience and regulation.
The amygdala plays a crucial role in the formation of emotional memories, particularly those associated with fear. Conversely, under conditions of high stress, the hippocampus, which is responsible for contextualizing memories in terms of space and time and facilitating memory recall, experiences suppression. One theoretical perspective posits that this hippocampal suppression may contribute to the flashbacks characteristic of PTSD. When individuals with PTSD encounter stimuli reminiscent of a traumatic event, the memory, having been improperly encoded, can lead to a perception that the event is reoccurring.
The amygdalocentric model of PTSD postulates that the amygdala exhibits heightened arousal and inadequate regulation by the medial prefrontal cortex and the hippocampus, especially during the process of extinction. This perspective aligns with the interpretation of PTSD as a syndrome characterized by impaired fear extinction capabilities.
The basolateral nucleus (BLA) of the amygdala mediates the comparison and associative learning between unconditioned and conditioned responses to stimuli, a process fundamental to the fear conditioning observed in PTSD. Activation of the central nucleus (CeA) of the amygdala by the BLA subsequently elaborates the fear response, encompassing behavioral reactions to threat and an exaggerated startle response. Descending inhibitory projections originating from the medial prefrontal cortex (mPFC) modulate the signal transmission from the BLA to the CeA, a mechanism hypothesized to be critical for the extinction of conditioned fear responses.
Although meta-analyses of functional neuroimaging studies generally report amygdala hyperactivity in PTSD, a substantial degree of heterogeneity exists, surpassing that observed in social anxiety disorder or phobic disorder. A comparison between dorsal (approximately the CeA) and ventral (approximately the BLA) amygdala clusters reveals more pronounced hyperactivity in the ventral cluster, whereas hypoactivity is evident in the dorsal cluster. This differential activity may account for both the blunted emotional responses in PTSD, potentially through desensitization in the CeA, and the prominent fear-related symptomatology.
A 2007 investigation demonstrated that Vietnam War combat veterans diagnosed with PTSD exhibited a 20% reduction in hippocampal volume compared to veterans without such symptoms. However, this specific finding was not corroborated in chronic PTSD patients who experienced trauma during an air show plane crash in Ramstein, Germany, in 1988.
Evidence indicates a reduction in endogenous cannabinoid levels, specifically anandamide, in individuals with PTSD, accompanied by a compensatory increase in cannabinoid receptors (CB1). An apparent correlation exists between elevated CB1 receptor availability in the amygdala and aberrant threat processing and hyperarousal among trauma survivors, though not with dysphoria.
A 2020 study did not provide evidence to support previous research conclusions suggesting that low IQ constitutes a risk factor for the development of PTSD.
Diagnosis
The National Institute for Health and Care Excellence (NICE) advises clinicians to become proficient with the spectrum of symptoms linked to functional impairment and with events recognized as contributing factors to PTSD development. During assessment, it is recommended to pose specific questions and to account for the frequency of traumatic experiences. A comprehensive assessment should encompass physical, psychological, and social needs, alongside a thorough risk assessment.
Diagnosing Post-Traumatic Stress Disorder (PTSD) presents challenges due to several factors:
- The inherent subjectivity of a majority of its diagnostic criteria, a characteristic shared by numerous other mental health conditions;
- The possibility of symptom over-reporting, which may occur when individuals are pursuing disability benefits or when PTSD is presented as a mitigating circumstance during criminal sentencing;
- The converse potential for under-reporting, often driven by factors such as social stigma, personal pride, or concerns that a PTSD diagnosis could restrict specific professional opportunities;
- The significant symptomatic overlap with other psychiatric conditions, including obsessive-compulsive disorder and generalized anxiety disorder;
- Its frequent comorbidity with other mental disorders, such as major depressive disorder and generalized anxiety disorder;
- The presence of substance use disorders, which frequently manifest with signs and symptoms similar to those observed in PTSD;
- The capacity of substance use disorders to heighten an individual's vulnerability to PTSD, intensify existing PTSD symptoms, or both;
- The reciprocal relationship where PTSD itself elevates the risk of developing substance use disorders; and
- The culturally diverse manifestation of symptoms, particularly concerning avoidance and emotional numbing, distressing nocturnal experiences, and somatic complaints.
Screening Methodologies
Several screening instruments are available for adults suspected of having PTSD, including the PTSD Checklist for DSM-5 (PCL-5) and the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5). The PCL-5, a 17-item checklist, also serves to monitor symptom severity and treatment efficacy.
Furthermore, various screening and assessment tools exist for pediatric and adolescent populations, such as the Child PTSD Symptom Scale (CPSS), the Child Trauma Screening Questionnaire, and the UCLA Post-traumatic Stress Disorder Reaction Index for DSM-IV.
Additionally, specific screening and assessment instruments have been developed for caregivers of very young children (aged six years and under). These instruments comprise the Young Child PTSD Screen, the Young Child PTSD Checklist, and the Diagnostic Infant and Preschool Assessment.
Diagnostic Assessment
The assessment of PTSD is fundamentally guided by evidence-based principles, incorporating a multimethod approach. Clinicians conducting PTSD evaluations frequently employ various standardized, clinician-administered interviews and instruments to establish a formal diagnosis. Prominent, reliable, and valid assessment tools for PTSD diagnosis, consistent with the DSM-5, include the Clinician-Administered PTSD Scale for the DSM-5 (CAPS-5), the PTSD Symptom Scale Interview (PSS-I-5), and the Structured Clinical Interview for DSM-5 – PTSD Module (SCID-5 PTSD Module).
Classification within DSM and ICD
In the DSM-IV, PTSD was categorized as an anxiety disorder; however, it was subsequently reclassified as a "trauma- and stressor-related disorder" in the DSM-5. The diagnostic criteria for PTSD in the DSM-5 delineate four distinct symptom clusters: re-experiencing, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity.
The International Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), designates PTSD (code F43.1) within the category of "Reaction to severe stress, and adjustment disorders." The ICD-10 diagnostic criteria for PTSD encompass re-experiencing, avoidance, and either heightened reactivity or an inability to recollect specific details pertinent to the traumatic event.
The ICD-11 diagnostic description for PTSD (code 6B40) specifies three core symptom groups: (1) re-experiencing, (2) avoidance, and (3) a heightened sense of threat. Notably, ICD-11 omits verbal thoughts concerning the traumatic event as a diagnostic symptom. It is anticipated that the application of ICD-11 will result in a lower prevalence of diagnosed PTSD compared to ICD-10 or DSM-5. Furthermore, ICD-11 introduces the identification of a distinct subgroup, Complex Post-Traumatic Stress Disorder (CPTSD; code 6B41), characterized by a history of multiple or prolonged traumas and exhibiting more significant functional impairment than individuals diagnosed solely with PTSD.
Differential Diagnosis
A diagnosis of PTSD necessitates documented exposure to an extreme stressor. In contrast, any stressor can precipitate an adjustment disorder, which is an appropriate diagnosis for symptom patterns that do not fulfill the full diagnostic criteria for PTSD.
The symptomatic presentation of acute stress disorder is defined by its onset and resolution within four weeks following the traumatic event. Should symptoms persist beyond this timeframe and align with the characteristics of PTSD, a diagnostic re-evaluation may lead to a revised diagnosis.
Obsessive-compulsive disorder (OCD) can be diagnosed when intrusive thoughts are recurrent but not directly associated with a particular traumatic experience.
Individuals subjected to extreme, prolonged, and repeated traumatization without any feasible means of escape may develop complex post-traumatic stress disorder (CPTSD). This condition arises from cumulative traumatic experiences rather than an isolated event and presents with additional symptoms, including a fragmented sense of self.
Prevention
Early engagement with cognitive behavioral therapy has demonstrated modest benefits. While critical incident stress management was previously proposed as a method for preventing PTSD, subsequent research indicates it may lead to adverse effects. A 2019 Cochrane review concluded that there was insufficient evidence to endorse this intervention, noting that "multiple session interventions may result in worse outcomes than no intervention, for some individuals." The World Health Organization advises against employing benzodiazepines and antidepressants for acute stress, defined as symptoms persisting for less than one month. Although some data supports hydrocortisone for prevention in adults, evidence for propranolol, escitalopram, temazepam, or gabapentin remains limited or absent.
Psychological Debriefing
Individuals exposed to trauma frequently undergo a procedure known as psychological debriefing, intended to avert PTSD. This process involves interviews designed to enable individuals to directly address the traumatic event, articulate their emotions to a counselor, and organize their memories of the experience. Nevertheless, multiple meta-analyses have concluded that psychological debriefing is ineffective, potentially detrimental, and does not mitigate the future risk of PTSD development. This finding applies equally to both single-session and multi-session interventions. By 2017, the American Psychological Association had categorized psychological debriefing as having No Research Support/Treatment is Potentially Harmful.
Early Intervention
Trauma-focused interventions administered within days or weeks following a potentially traumatic event have been shown to reduce PTSD symptoms. Analogous to psychological debriefing, the primary objective of early intervention is to diminish the intensity and frequency of stress-related symptoms, thereby preventing the onset or relapse of mental disorders and mitigating subsequent distress during the recovery phase.
Risk-Targeted Interventions
Risk-targeted interventions are designed to ameliorate the impact of particular formative information or events. These interventions may focus on modeling normative behaviors, providing task-specific instruction, or disseminating information pertinent to the event.
Management
Combination Therapy
The majority of combination therapies, encompassing both psychological and pharmacotherapeutic approaches, do not appear to surpass the effectiveness of psychological therapy alone. An exception may be MDMA-assisted psychotherapy, though its evidence for efficacy remains limited.
In Canada, the distribution of MDMA is restricted and requires application to and approval by Health Canada. Australian regulations permit its prescription for PTSD treatment by specifically authorized psychiatrists. Despite previously considering MDMA a "breakthrough therapy," the FDA declined its approval for PTSD treatment in 2024, citing concerns regarding trial design and safety.
Certain reviews indicate that MDMA-assisted psychotherapy mitigates PTSD symptoms when compared to control therapies and exhibits a generally acceptable safety profile. However, its broader applicability is constrained by small sample sizes and reported adverse effects. Furthermore, the potential therapeutic benefits of MDMA might be overstated due to issues such as participant unblinding and expectancy biases.
In 2025, the FDA conferred Breakthrough Therapy designation upon methylone, indicating its potential for the treatment of PTSD.
Counseling
Therapies demonstrating the most robust evidence include behavioral and cognitive-behavioral approaches, specifically prolonged exposure therapy, cognitive processing therapy (CPT), and eye movement desensitization and reprocessing (EMDR). Additionally, some evidence supports the efficacy of brief eclectic psychotherapy (BEP), narrative exposure therapy (NET), and written exposure therapy.
A 2019 Cochrane review assessed the efficacy of couples and family therapies for post-traumatic stress disorder (PTSD) treatment, contrasting them with no intervention, individual therapies, and group therapies. The review concluded that insufficient research existed on couples therapies to ascertain their substantive benefits, although initial randomized controlled trials indicated potential advantages in mitigating PTSD symptoms.
A meta-analysis comparing Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Behavioral Therapy (CBT) revealed no significant difference in their effectiveness for treating PTSD; however, the specific contribution of the eye movement component in EMDR to treatment outcomes remains ambiguous. Furthermore, a separate meta-analysis focusing on pediatric and adolescent populations similarly concluded that EMDR demonstrated comparable efficacy to CBT.
Children diagnosed with PTSD exhibit a significantly higher propensity to seek treatment within a school setting, primarily due to its accessibility and convenience, compared to accessing services at a free clinic.
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy (CBT) aims to modify an individual's emotional and behavioral responses by altering the cognitive or behavioral patterns, or both, that contribute to negative affect. A 2018 systematic review provided robust evidence supporting the efficacy of CBT-exposure therapy in reducing symptoms of PTSD and depression, and in achieving remission of a PTSD diagnosis. Consequently, CBT is recognized as an effective intervention for PTSD and is designated as the standard of care by the United States Department of Defense.
Within CBT, patients are guided to recognize and subsequently reframe thoughts that induce fear or distress, substituting them with less anxiety-provoking cognitions. The primary objective is to elucidate the causal link between specific event-related thoughts and the manifestation of PTSD-related stress. Research evaluating an online iteration of CBT for individuals with mild-to-moderate PTSD indicated that this digital modality was equally effective and more cost-efficient than traditional in-person therapy. A 2021 Cochrane review further examined internet-based CBT, reporting comparable therapeutic benefits to face-to-face delivery; however, the evidential quality was deemed low due to the limited number of included trials.
Exposure therapy, a specialized form of cognitive behavioral therapy, guides trauma survivors through a process of re-experiencing distressing trauma-related memories and cues. This systematic re-engagement aims to foster habituation and facilitate the adaptive emotional processing of the traumatic memory. The majority of exposure therapy protocols integrate both imaginal confrontation with traumatic memories and in-vivo exposure to trauma reminders, a combined approach that has demonstrated therapeutic efficacy in the management of PTSD.
Several organizations have formally recognized the imperative for exposure-based interventions. Notably, the U.S. Department of Veterans Affairs has proactively implemented training programs for its mental health treatment personnel in prolonged exposure therapy and cognitive processing therapy, aiming to enhance the care provided to U.S. veterans suffering from PTSD.
Contemporary research into contextually based third-generation behavioral therapies indicates their potential to yield outcomes comparable to those achieved by more extensively validated therapeutic approaches. A substantial number of these methodologies incorporate a significant exposure component and have exhibited effectiveness in addressing both the core symptoms of PTSD and comorbid depressive symptomatology.
Eye Movement Desensitization and Reprocessing
Eye Movement Desensitization and Reprocessing (EMDR) constitutes a psychotherapeutic modality conceptualized and investigated by Francine Shapiro. Shapiro observed that her eyes exhibited rapid movements when she personally contemplated distressing memories. She subsequently noted that by consciously controlling her eye movements during such contemplation, the associated thoughts became less distressing.
In 2002, Shapiro and Maxfield introduced the adaptive information processing theory, which posits a mechanism for EMDR's efficacy. This theoretical framework suggests that eye movements can facilitate the emotional processing of memories, thereby reconfiguring an individual's memory to integrate more adaptive information. During EMDR, the therapist guides the patient to perform voluntary rapid eye movements while the patient concentrates on memories, emotions, or cognitions related to a specific trauma. While hand movements are typically employed to direct ocular motion, alternative stimuli such as hand-tapping or auditory tones can also be utilized. EMDR shares structural similarities with cognitive behavioral therapy, incorporating elements of exposure (revisiting the traumatic event), cognitive restructuring, and relaxation/self-monitoring. Nevertheless, a key distinguishing feature of EMDR is its emphasis on internal contemplation of the traumatic experience rather than verbal articulation during exposure.
Multiple scientific investigations have assessed the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) across adult, pediatric, and adolescent populations. A 2018 systematic review update indicated moderate evidence supporting EMDR's efficacy in "reducing PTSD symptoms, achieving diagnostic remission, and alleviating depressive symptoms."
A recent meta-analysis of randomized controlled trials involving children and adolescents demonstrated that EMDR was at least as effective as cognitive behavioral therapy (CBT) and outperformed waitlist or placebo conditions. Preliminary evidence suggested a potential role for EMDR in depression prevention. However, adverse effects remained largely unexplored. Notably, the therapeutic benefits appeared more pronounced for women with a history of sexual assault compared to individuals who had experienced other forms of traumatic events, such as accidents, physical assaults, or war.
The therapeutic benefits of EMDR may not be critically dependent on its eye movement component.
Interpersonal Psychotherapy
Other therapeutic strategies, particularly those incorporating social support, may also hold significance. An open trial investigating interpersonal psychotherapy documented substantial rates of PTSD symptom remission without the application of exposure techniques.
Pharmacotherapy
Four antidepressant medications—sertraline, fluoxetine, paroxetine, and venlafaxine—have demonstrated a small to modest therapeutic advantage over placebo.
Antidepressant Medications
Selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) may offer some amelioration of PTSD symptoms. While tricyclic antidepressants exhibit comparable efficacy, their tolerability profile is generally inferior. Empirical data supports a minor to moderate improvement with sertraline, fluoxetine, paroxetine, and venlafaxine, leading to their classification as first-line pharmacotherapy for PTSD. Specifically, the SSRIs paroxetine and sertraline have received approval from the U.S. Food and Drug Administration (FDA) for the management of PTSD.
Benzodiazepines
The application of benzodiazepines in PTSD treatment remains controversial, primarily due to evidence suggesting a potential for exacerbating PTSD symptoms. Certain experts contend that benzodiazepine use is contraindicated in acute stress given their capacity to induce dissociation. Despite these concerns, some clinicians cautiously employ benzodiazepines for short-term management of anxiety and insomnia. Although these agents can mitigate acute anxiety, consistent evidence is lacking to support their role in preventing PTSD development; conversely, they may elevate the risk of developing PTSD by a factor of 2 to 5. Consequently, some recommendations advise against benzodiazepine administration immediately following a traumatic event, citing the potential for increased PTSD-related symptomatology.
Benzodiazepines may diminish the efficacy of psychotherapeutic interventions, and there is some indication that they could contribute to the onset and persistence of PTSD. In individuals already diagnosed with PTSD, benzodiazepines have the potential to worsen and prolong the illness trajectory by impairing psychotherapy outcomes and by inducing or exacerbating aggression, depression (including suicidal ideation), and substance use. Associated disadvantages encompass the risk of developing benzodiazepine dependence, tolerance (where short-term benefits attenuate over time), and withdrawal syndrome. Furthermore, individuals with PTSD, even those without a prior history of alcohol or drug misuse, face an elevated risk of benzodiazepine abuse.
Given the availability of numerous alternative treatments for PTSD that offer superior efficacy and fewer risks, benzodiazepines are generally considered relatively contraindicated unless all other therapeutic options have been exhausted.
Benzodiazepines also present a risk of disinhibition, which is associated with suicidality, and some evidence indicates that their use might impede or postpone more definitive PTSD treatments.
Conversely, some research implies that the risks associated with benzodiazepine use for PTSD may be lower than initially presumed, as the hazard ratio significantly decreases when antidepressant use is factored into the analysis.
Prazosin
Prazosin, an alpha-1 adrenergic antagonist, has been administered to veterans with PTSD to mitigate nightmares. However, studies reveal inconsistencies in symptom improvement, optimal dosages, and overall efficacy within this demographic.
Glucocorticoids
Glucocorticoids may offer short-term therapeutic utility in safeguarding against neurodegeneration, which is often induced by the prolonged stress response characteristic of PTSD. Nevertheless, extended administration of these agents could paradoxically foster neurodegeneration.
Cannabinoids
Cannabis is not currently recommended for treating post-traumatic stress disorder (PTSD) due to a lack of scientific evidence supporting the efficacy of cannabinoids. Nevertheless, cannabis and its derived products are widely utilized by U.S. veterans diagnosed with PTSD.
Nabilone, a cannabinoid, is occasionally prescribed for PTSD-related nightmares. While some short-term benefits have been observed, adverse effects are prevalent, and its efficacy remains insufficiently studied. Concurrently, a growing number of states have authorized and legalized medical cannabis for PTSD treatment.
Additional Approaches
Physical Activity, Exercise, and Sport
Physical activity can significantly impact an individual's psychological and physical well-being. The U.S. National Center for PTSD advocates for moderate exercise as a strategy to divert attention from distressing emotions, enhance self-esteem, and foster a renewed sense of control. Consultation with a physician is advised prior to initiating any exercise regimen.
Play Therapy for Pediatric Patients
Play is hypothesized to facilitate children's integration of internal thoughts with external realities, thereby linking concrete experiences with abstract concepts. Repetitive play may also serve as a mechanism through which a child re-experiences traumatic events, potentially indicating a symptom of trauma in pediatric or adolescent populations. Despite its widespread application, insufficient comparative studies exist between groups of children undergoing and not undergoing play therapy, thus precluding a comprehensive understanding of its therapeutic effects.
Military Support Programs
Veterans of the conflicts in Iraq and Afghanistan have frequently encountered substantial physical, emotional, and relational challenges. In response, the United States Marine Corps has implemented initiatives designed to facilitate their reintegration into civilian life, particularly concerning relationships with spouses and family members, by enhancing communication and mutual understanding of shared experiences. The Walter Reed Army Institute of Research (WRAIR) developed the Battlemind program to aid service members in preventing or mitigating PTSD and associated issues. Furthermore, the Wounded Warrior Project collaborated with the U.S. Department of Veterans Affairs to establish the Warrior Care Network, a nationwide system of PTSD treatment facilities.
Nightmare Management
In 2020, the United States Food and Drug Administration approved the marketing of NightWare, an Apple Watch application. This application seeks to enhance sleep quality for individuals experiencing PTSD-related nightmares by employing vibrations upon detecting a nightmare, based on real-time monitoring of heart rate and body movement.
Epidemiological Data
The prevalence rates of PTSD within various populations are subject to ongoing discussion. However, despite modifications in diagnostic approaches and criteria for defining PTSD between 1997 and 2013, epidemiological rates have remained largely consistent. The majority of currently dependable epidemiological data for PTSD relies on DSM-IV criteria, given that the DSM-5 was not implemented until 2013.
The World Health Organization, an agency of the United Nations, provides estimations of PTSD's impact for its member states, with the most recent available data dating from 2004. When examining the 25 most populous nations, ranked by their overall age-standardized Disability-Adjusted Life Year (DALY) rate, the upper half of this ranking predominantly comprises Asian/Pacific countries, the United States, and Egypt. Ranking these nations solely by male or female rates yields comparable results, albeit with diminished statistical significance. This reduction in significance stems from a considerably narrower score range in single-sex rankings (4 for women, 3 for men, versus 14 for the overall score range), which implies that intra-country disparities between female and male rates are the primary determinants of inter-country distinctions.
In 2017, the global lifetime prevalence of PTSD was reported at 3.9%, derived from a survey indicating that 5.6% of respondents had experienced trauma. Income emerged as the principal determinant influencing treatment-seeking behavior, a crucial factor in mitigating PTSD development post-trauma. Conversely, younger age, female gender, and lower socioeconomic status (characterized by less education, reduced individual income, and unemployment) were all correlated with a decreased propensity to seek treatment.
United States Data
PTSD affects approximately 5% of the adult population in the United States annually. The National Comorbidity Survey Replication has determined that the lifetime prevalence of PTSD among American adults is 6.8%, with women (9.7%) exhibiting more than double the likelihood of men (3.6%) to experience PTSD during their lives. Over 60% of both men and women encounter at least one traumatic event throughout their lives. For men, the most frequently reported traumatic experiences include rape, combat exposure, and childhood neglect or physical abuse. Women commonly report incidents such as rape, sexual molestation, physical assault, threats involving a weapon, and childhood physical abuse. Among individuals with lifetime PTSD, 88% of men and 79% of women also present with at least one comorbid psychiatric disorder. The most prevalent comorbid conditions are major depressive disorder, affecting 48% of men and 49% of women, and lifetime alcohol use disorder or dependence, observed in 51.9% of men and 27.9% of women.
Military Combat
The U.S. Department of Veterans Affairs estimates that 830,000 veterans of the Vietnam War experienced symptoms indicative of PTSD. The National Vietnam Veterans' Readjustment Study (NVVRS) revealed that 15% of male and 9% of female Vietnam veterans met the criteria for PTSD at the time of the study. The lifetime prevalence of PTSD among these veterans was reported as 31% for males and 27% for females. A subsequent reanalysis of the NVVRS data, combined with an examination of data from the Matsunaga Vietnam Veterans Project by Schnurr, Lunney, Sengupta, and Waelde, indicated that a substantial majority of Vietnam veterans exhibited PTSD symptoms, though not necessarily the full disorder, a finding that diverged from the initial NVVRS analysis. Specifically, four out of five veterans reported recent symptoms when surveyed 20–25 years after their service in Vietnam.
A 2011 investigation conducted by Georgia State University and San Diego State University identified a significant increase in PTSD diagnosis rates among military personnel under specific conditions. These conditions included deployment to combat zones, tours of duty exceeding one year, direct combat exposure, or sustaining injuries. Military personnel deployed to combat zones demonstrated a 12.1 percentage point higher probability of receiving a PTSD diagnosis compared to their active-duty counterparts stationed in non-combat areas. Furthermore, individuals serving over 12 months in a combat zone were 14.3 percentage points more likely to be diagnosed with PTSD than those whose service in such zones lasted less than one year.
Direct engagement in an enemy firefight correlated with an 18.3 percentage point rise in the probability of developing PTSD. Similarly, sustaining wounds or injuries during combat was linked to a 23.9 percentage point increase in the likelihood of a PTSD diagnosis. For the 2.16 million U.S. military personnel deployed to combat zones between 2001 and 2010, the estimated two-year treatment costs for combat-related PTSD ranged from $1.54 billion to $2.69 billion.
By 2013, PTSD prevalence among veterans returning from conflicts in Iraq and Afghanistan was estimated to be as high as 20%. Concurrently, in 2013, 13% of veterans returning from Iraq faced unemployment.
Human-Made Disasters
The September 11 attacks resulted in nearly 3,000 fatalities and approximately 6,000 injuries. Recovery operations involved a diverse group, including first responders (police, firefighters, and emergency medical technicians), sanitation workers, and volunteers. The prevalence of probable PTSD within these highly exposed populations was assessed through multiple studies employing in-person, telephone, and online interviews and questionnaires. Initially, the overall prevalence of PTSD was highest immediately after the attacks, subsequently declining over time. Nevertheless, notable disparities emerged among various categories of recovery workers. For first responders, the rate of probable PTSD was lowest directly following the attacks, subsequently increasing from a range of 4.8–7.8% to 7.4–16.5% between the 5–6 year follow-up and a subsequent evaluation.
A comparison between traditional responders and non-traditional responders (volunteers) revealed that the probable PTSD prevalence 2.5 years post-initial 7% and 17.2% respectively. Volunteer engagement in tasks outside their typical occupational roles constituted a significant risk factor for PTSD. Additional identified risk factors encompassed the intensity of exposure, an earlier commencement date, the duration of time spent at the site, and persistent, adverse reminders of the traumatic event.
Research has also investigated the social ramifications of the September 11 attacks. A study evaluating alcohol consumption among World Trade Center workers utilized the CAGE questionnaire for alcohol use disorder. Nearly 50% of these workers, who identified as alcohol users, reported increased drinking during the rescue operations. Furthermore, approximately a quarter of these individuals indicated higher alcohol intake during the subsequent recovery phase. The risk of developing an alcohol problem was found to be twice as high for those diagnosed with probable PTSD compared to individuals without psychological morbidity. Social disability, characterized by disruptions in family, work, and social life, was also examined within this cohort as another social consequence of the attacks. The likelihood of developing social disability increased 17-fold for those categorized with probable PTSD.
Anthropology
Cultural and medical anthropologists have raised concerns regarding the cross-cultural applicability of PTSD diagnostic criteria.
Trauma, and the subsequent development of PTSD, frequently manifests at the extreme boundaries of human suffering, pain, and fear. The vivid images and experiences re-encountered in PTSD often resist straightforward linguistic articulation. Consequently, the cross-linguistic translation of these experiences presents significant challenges, inherently limiting the scope of trauma research predominantly conducted within a Euro-American framework.
For instance, ethnopsychological investigations in Nepal have revealed that indigenous idioms and concepts pertaining to trauma frequently lack direct equivalents in Western terminology. The term piDaa, while potentially correlating with trauma or suffering, also carries the connotation that individuals experiencing piDaa are considered paagal (mad), leading to significant social stigma. This highlights the imperative for culturally sensitive and precisely adapted support interventions. More broadly, diverse cultures process and recall traumatic events through distinct linguistic and cultural frameworks. Consequently, cultural and medical anthropologists have challenged the universal applicability of PTSD diagnostic criteria, particularly those defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) and developed within a Euro-American psychological paradigm.
A significant scarcity of research persists regarding the conceptual frameworks of trauma in non-Western cultures. Furthermore, limited evidence supports the therapeutic efficacy of integrating local idioms of distress into a culturally specific disorder originating from the post-Vietnam era, a practice that anthropologists contend contributes to category fallacy. In numerous cultures, a singular linguistic equivalent for PTSD does not exist, as psychological trauma is often understood as a multifaceted concept with diverse forms of expression.
In many non-Western cultures, the attribution of trauma's effects to a spiritual affliction is prevalent, with idioms like "soul loss" and "weak heart" signifying a tendency to associate suffering with a spirit-body or heart-body dichotomy. These expressions underscore the importance collectivist cultures place on addressing trauma through familial, cultural, and religious practices, thereby circumventing the stigma often associated with a purely mind-body perspective. Consequently, the application of PTSD diagnostics within these communities is frequently ineffective and potentially harmful. For trauma that transcends individual experience, such as the widespread impact of war, anthropologists propose that terms like "social suffering" or "cultural bereavement" offer more appropriate and beneficial conceptualizations.
Conflict profoundly impacts every societal dimension, with prolonged exposure to widespread violence potentially inducing 'continuous suffering' among civilians, military personnel, and populations in neighboring regions. The diagnostic criteria for PTSD, incorporated into the DSM in 1980, were initially formulated by clinicians and psychiatrists based on observations of American veterans of the Vietnam War. Despite regular revisions and updates, the DSM's capacity to fully encapsulate the disorder is constrained by its inherent Americanization, or Westernization. This implies that characteristics recognized as PTSD in Western societies may not directly correspond or translate effectively across diverse global cultures. For instance, displaced individuals in Burundi, an African nation, exhibited symptoms of depression and anxiety, although only a limited number of symptoms specifically indicative of PTSD were observed.
A comparable study observed that Sudanese refugees resettled in Uganda primarily expressed concerns regarding material deprivation, such as insufficient food, shelter, and healthcare, rather than psychological distress. Many of these refugees exhibited no symptoms, with only a small number developing anxiety and depression. While war-related stresses and traumas become deeply embedded in individuals, their manifestation varies across cultures, and the rigid diagnostic criteria for PTSD may not adequately accommodate culturally specific responses.
Veterans
United States
The United States offers various benefits to veterans diagnosed by the Department of Veterans Affairs (VA) with PTSD that originated during or as a consequence of their military service. These provisions can encompass tax-exempt financial compensation, complimentary or subsidized mental health services and other medical care, vocational rehabilitation, employment support, and assistance for independent living.
United Kingdom
In the United Kingdom, numerous charitable and service organizations are committed to assisting veterans in their transition to civilian life. The Royal British Legion and the more recently founded Help for Heroes represent two prominent British veterans' organizations that have consistently championed veterans' causes. However, controversy has arisen regarding the National Health Service's (NHS) perceived inadequacy in addressing veterans' mental health issues, with accusations of "dumping" veterans onto charities like Combat Stress.
Canada
Veterans Affairs Canada offers comprehensive assistance to disabled veterans, encompassing rehabilitation services, financial aid, employment placement, healthcare, disability compensation, peer support initiatives, and family support programs.
History
Historical analysis of written records from 1300 to 600 BCE has revealed manifestations akin to PTSD among soldiers in ancient Assyria. These Assyrian military personnel typically served three-year combat rotations before repatriation and reportedly encountered significant difficulties in integrating their wartime experiences with their civilian existence.
Furthermore, scholarly connections have been established between the behaviors of Viking berserkers and the hyperarousal symptoms characteristic of post-traumatic stress disorder.
Psychiatrist Jonathan Shay posits that Lady Percy's soliloquy in William Shakespeare's play Henry IV, Part 1 (act 2, scene 3, lines 40–62), composed circa 1597, offers an exceptionally precise depiction of the symptomatic cluster associated with PTSD.
Numerous historical wartime diagnoses, including "railway spine," "stress syndrome," "nostalgia," "soldier's heart," "shell shock," "battle fatigue," "combat stress reaction," and "traumatic war neurosis," are presently recognized as correlates of PTSD.
The strong correlation between combat exposure and PTSD is indisputable; Stéphane Audoin-Rouzeau and Annette Becker note that "One-tenth of mobilized American men were hospitalized for mental disturbances between 1942 and 1945, and, after thirty-five days of uninterrupted combat, 98% of them manifested psychiatric disturbances in varying degrees."
The first edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-I), published in 1952, featured the diagnosis of "gross stress reaction," which exhibits conceptual parallels with the contemporary definition and comprehension of PTSD. Gross stress reaction was characterized as a typical personality's utilization of established coping mechanisms to manage overwhelming fear in response to highly stressful circumstances. The diagnostic description explicitly linked this condition to both combat scenarios and "civilian catastrophe."
The inclusion of the term "post-traumatic stress disorder" in the DSM-III was significantly shaped by the experiences and psychological states of U.S. military veterans from the Vietnam War. Consequently, a substantial portion of the extant published research concerning PTSD originates from studies conducted on Vietnam War veterans.
Given the initial prominent emphasis on PTSD as a combat-related disorder during its conceptual development in the post-Vietnam War era, Ann Wolbert Burgess and Lynda Lytle Holmstrom introduced the definition of rape trauma syndrome (RTS) in 1975. Their aim was to highlight the notable commonalities between the experiences of returning soldiers and those of rape victims, thereby facilitating a broader understanding of PTSD's etiological factors.
In early 1978, the diagnostic nomenclature "post-traumatic stress disorder" received its initial recommendation within a working group's findings presented to the Committee of Reactive Disorders.
A 1979 United States Air Force (USAF) study investigated individuals, both civilian and military, involved in the recovery and identification of remains from the Jonestown tragedy. These remains, a third of which belonged to children, had been deceased for several days. The study employed the term "dysphoria" to characterize symptoms resembling those of post-traumatic stress disorder (PTSD).
Following the official recognition of PTSD as an American psychiatric diagnosis in the 1980 publication of DSM-III, a rapid escalation occurred in personal injury lawsuits (tort claims) alleging plaintiffs suffered from PTSD. Nevertheless, judges and juries, acting as triers of fact, frequently perceived the diagnostic criteria for PTSD as imprecise, a sentiment echoed by legal scholars, trauma specialists, forensic psychologists, and forensic psychiatrists. The DSM-III (1980) formally designated the condition as "posttraumatic stress disorder."
Extensive professional discourse and debates, conducted through academic journals, conferences, and among thought leaders, culminated in a more precisely articulated set of diagnostic criteria within DSM-IV (1994), particularly regarding the definition of a "traumatic event." The DSM-IV categorized PTSD as an anxiety disorder. Concurrently, the ICD-10, introduced in 1994, rendered the condition's spelling as "post-traumatic stress disorder."
In 2012, researchers associated with the Grady Trauma Project underscored a prevalent inclination to emphasize the combat-related aspects of PTSD. They noted that "less public awareness has focused on civilian PTSD, which results from trauma exposure that is not combat related..." and that "much of the research on civilian PTSD has focused on the sequelae of a single, disastrous event, such as the Oklahoma City bombing, September 11th attacks, and Hurricane Katrina." This imbalance in research focus reinforced the widespread, yet inaccurate, perception of an exclusive link between combat and PTSD. Such a narrow perspective can be misleading for comprehending the full implications and scope of PTSD as a neurological disorder.
The DSM-5, published in 2013, established a novel diagnostic category, "trauma and stressor-related disorders," under which PTSD is now classified.
The 2014 National Comorbidity Survey in the United States indicated that "the traumas most commonly associated with PTSD are combat exposure and witnessing among men and rape and sexual molestation among women."
Terminology
The Diagnostic and Statistical Manual of Mental Disorders consistently omits a hyphen between "post" and "traumatic," leading the DSM-5 to list the disorder as posttraumatic stress disorder. Conversely, numerous scientific journal articles and other scholarly publications frequently hyphenate the disorder's name, viz., "post-traumatic stress disorder." Dictionaries also exhibit variation in the preferred spelling; for instance, the Collins English Dictionary – Complete and Unabridged employs the hyphenated form, whereas the American Heritage Dictionary of the English Language, Fifth Edition and the Random House Kernerman Webster's College Dictionary present the non-hyphenated spelling.
To mitigate the stigma linked with the term "disorder," certain authors have adopted alternative nomenclature, such as "post-traumatic stress syndrome," "post-traumatic stress symptoms" ("PTSS"), or, particularly within the U.S. Department of Defense, simply "post-traumatic stress" ("PTS").
Comedian George Carlin critiqued the "euphemism treadmill" phenomenon, which he argued progressively altered the terminology for PTSD throughout the 20th century. This evolution included "shell shock" during the First World War, "battle fatigue" in the Second World War, "operational exhaustion" during the Korean War, and the contemporary "post-traumatic stress disorder," a term coined during the Vietnam War. Carlin remarked that this final iteration "added a hyphen" and "completely burie[s] [the pain] under jargon." He further contended that the specific designation of the condition directly influenced how veteran soldiers with PTSD were perceived and treated by civilian populations over time. In the English-speaking world, other historical terms for PTSD include "bossies," which was used during the South African Border War.
Research
The majority of current understanding concerning PTSD originates from research conducted in high-income nations.
To investigate neurological and neurobehavioral symptoms observed in veterans from recent conflicts in Iraq and Afghanistan, researchers at the Roskamp Institute and the James A. Haley Veteran's Hospital (Tampa) developed an animal model to examine the effects of mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD). In this laboratory setting, mice were subjected to repeated unpredictable stressors, specifically predator odor while restrained, and physical trauma via inescapable foot-shock, which was also combined with mTBI. The study revealed that animals with PTSD exhibited recall of traumatic memories, anxiety, and impaired social behavior. Conversely, animals exposed to both mTBI and PTSD displayed a pattern of disinhibitory-like behavior, with mTBI mitigating both contextual fear and social behavior deficits observed in PTSD-only animals. Furthermore, an analysis of neuroendocrine and neuroimmune plasma responses indicated a trend towards increased corticosterone levels in both the PTSD and combined mTBI/PTSD groups, consistent with findings from other animal studies.
Stellate ganglion block is currently being investigated as an experimental therapeutic procedure for post-traumatic stress disorder.
Psychotherapy
Trauma-focused psychotherapies for post-traumatic stress disorder (PTSD), often referred to as "exposure-based" or "exposure" psychotherapies, include modalities such as prolonged exposure therapy (PE), eye movement desensitization and reprocessing (EMDR), and cognitive processing therapy (CPT). These approaches possess the strongest empirical support for efficacy and are widely recommended as first-line treatments for PTSD across nearly all clinical practice guidelines. Exposure-based psychotherapies have demonstrated effectiveness for PTSD stemming from various trauma types, including combat, sexual assault, and natural disasters. However, a notable challenge associated with many trauma-focused psychotherapies is their propensity for high patient drop-out rates.
The majority of systematic reviews and clinical guidelines suggest that psychotherapies for post-traumatic stress disorder (PTSD), predominantly trauma-focused approaches, exhibit greater efficacy than pharmacotherapy (medication). Nevertheless, some reviews propose that exposure-based psychotherapies for PTSD and pharmacotherapy may offer comparable effectiveness. While interpersonal psychotherapy presents preliminary evidence of probable efficacy, further research is required to establish definitive conclusions regarding its role in PTSD treatment.
Notes
This article integrates content from a free work, licensed under CC BY-SA 3.0 IGO. The text is derived from A Lifeline to Learning: Leveraging Mobile Technology to Support Education for Refugees, published by UNESCO.
This article incorporates text from a free content work. Licensed under CC BY-SA 3.0 IGO. Text taken from A Lifeline to learning: leveraging mobile technology to support education for refugees, UNESCO, UNESCO. UNESCO.
Information on post-traumatic stress disorder from The National Child Traumatic Stress Network.
- Post traumatic stress disorder information from The National Child Traumatic Stress Network
- Informational resources provided by The University of Queensland School of Medicine.
- The American Psychological Association's practice parameters for the assessment and treatment of post-traumatic stress disorder (Updated 2025).
- Professional resources available from the VA National PTSD Center.